[Federal Register Volume 83, Number 10 (Tuesday, January 16, 2018)]
[Notices]
[Pages 2215-2216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00506]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Johnson 
Matthey Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before March 19, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
November 10, 2017, Johnson Matthey Inc., Pharmaceuticals Materials, 900 
River Road, Conshohocken, Pennsylvania 19428 applied to be registered 
as a bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..............     2010  I
Amphetamine............................     1100  II
Methylphenidate........................     1724  II
Codeine................................     9050  II
Oxycodone..............................     9143  II
Diphenoxylate..........................     9170  II
Hydrocodone............................     9193  II
Meperidine.............................     9230  II
Methadone..............................     9250  II
Methadone intermediate.................     9254  II
Morphine...............................     9300  II
Thebaine...............................     9333  II
Opium tincture.........................     9630  II
------------------------------------------------------------------------


[[Page 2216]]

    The company plans to manufacture the listed controlled substances 
in bulk for either internal use or for sale to its customers. Thebaine 
(9333) will be used to manufacture other controlled substances for sale 
in bulk to its customers.

    Dated: January 4, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-00506 Filed 1-12-18; 8:45 am]
 BILLING CODE 4410-09-P